CH633708A5 - COSMETIC PREPARATION. - Google Patents
COSMETIC PREPARATION. Download PDFInfo
- Publication number
- CH633708A5 CH633708A5 CH896380A CH896380A CH633708A5 CH 633708 A5 CH633708 A5 CH 633708A5 CH 896380 A CH896380 A CH 896380A CH 896380 A CH896380 A CH 896380A CH 633708 A5 CH633708 A5 CH 633708A5
- Authority
- CH
- Switzerland
- Prior art keywords
- nerolidol
- skin
- cosmetic preparation
- preparation according
- day cream
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 30
- 239000002537 cosmetic Substances 0.000 title claims description 21
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims description 39
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims description 39
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims description 39
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 4
- 229940101267 panthenol Drugs 0.000 claims description 4
- 235000020957 pantothenol Nutrition 0.000 claims description 4
- 239000011619 pantothenol Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 description 24
- 239000003925 fat Substances 0.000 description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 5
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 5
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 5
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 5
- 229950001798 amiphenazole Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 5
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- HBDHXDBPCVDGQN-FPLPWBNLSA-N propan-2-yl (z)-tetradec-9-enoate Chemical compound CCCC\C=C/CCCCCCCC(=O)OC(C)C HBDHXDBPCVDGQN-FPLPWBNLSA-N 0.000 description 5
- 229940031439 squalene Drugs 0.000 description 5
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 3
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 3
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 3
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- -1 Isopropyl myristinate glycerol monostearate Chemical compound 0.000 description 3
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 3
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 229940058690 lanosterol Drugs 0.000 description 3
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- QMYDVDBERNLWKB-UHFFFAOYSA-N propane-1,2-diol;hydrate Chemical compound O.CC(O)CO QMYDVDBERNLWKB-UHFFFAOYSA-N 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000077 insect repellent Substances 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 229910003873 O—P—O Inorganic materials 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 239000002812 cholic acid derivative Substances 0.000 description 1
- 150000001842 cholic acids Chemical class 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- SDXCRASCLFBFND-SDNWHVSQSA-N nerolidyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CCC(C)(C=C)OP(O)(=O)OP(O)(O)=O SDXCRASCLFBFND-SDNWHVSQSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/0229—Sticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Description
Die Erfindung betrifft eine kosmetische Zubereitung, welche Nerolidol, d.h. 3,7,ll-Trimethyl-l,6,10-dodecatrien-3-ol, dessen Ester und/oder Äther als hautpflegende Komponente enthält. The invention relates to a cosmetic preparation which contains nerolidol, i.e. 3,7, ll-trimethyl-l, 6,10-dodecatrien-3-ol, whose ester and / or ether contains as a skin-care component.
Es ist bereits bekannt, in kosmetischen Zubereitungen als hautpflegende Komponente Squalen, Lanosterin, Cholesterin, wie auch Derivate von Cholsäuren, einzusetzen [G. A. Nowak, «Die kosmetischen Präparate» (2. Auflage), Verlag für ehem. Industrie (H. Ziolkowsky KG, Augsburg) S. 23 und 189; Karlheinz Schräder, «Grundlagen und Rezepturen der Kosmetika» (Dr. Alfred Hüthig Verlag, Heidelberg) S. 49,102 und 146; Dr. R.A. Eckstein, «Biokosmetik: Aus Forschung und Praxis» (1976, Linde Eckstein KG, Nürnberg) S. 380]. Leider sind die genannten Produkte Squalen, Lanosterin und Cholesterin zum Teil schwer zugänglich, zum Teil kostspielig, wobei die Zugänglichkeit zum Teil auch noch von ökonomischen und politischen Faktoren abhängt. Beispielsweise wird Squalen aus Haifischleberöl gewonnen, das immer schwieriger in der erforderlichen Qualität erhalten werden kann. Th. R. Davis, Cosmetics and Toi-letries 91 (1976) 33 hat bereits versucht, dieses Naturprodukt durch synthetische Stoffe zu ersetzen. It is already known to use squalene, lanosterol, cholesterol and derivatives of cholic acids in cosmetic preparations as skin-care components [G. A. Nowak, “The Cosmetic Preparations” (2nd edition), Publishing House for Former Industries (H. Ziolkowsky KG, Augsburg) pp. 23 and 189; Karlheinz Schräder, “Basics and formulations of cosmetics” (Dr. Alfred Hüthig Verlag, Heidelberg) pp. 49,102 and 146; Dr. R.A. Eckstein, “Organic Cosmetics: From Research and Practice” (1976, Linde Eckstein KG, Nuremberg) p. 380]. Unfortunately, the above-mentioned products squalene, lanosterol and cholesterol are sometimes difficult to access and sometimes expensive, although accessibility also depends on economic and political factors. For example, squalene is obtained from shark liver oil, which is increasingly difficult to obtain in the required quality. Th. R. Davis, Cosmetics and Toi-letries 91 (1976) 33 has already tried to replace this natural product with synthetic substances.
Aufgabe der vorliegenden Erfindung war es, die obengenannten hautpflegenden Substanzen in kosmetischen Zubereitungen durch andere, leichter zugängliche und ökonomisch vorteilhaftere Substanzen zu ersetzen. Durch die Änderung der Rezeptur sollte jedoch weder Stabilität noch Konsistenz oder Aussehen der kosmetischen Zubereitungen nachteilig verändert werden. The object of the present invention was to replace the above-mentioned skin-care substances in cosmetic preparations by other, more accessible and economically more advantageous substances. However, changing the formulation should not adversely change the stability, consistency or appearance of the cosmetic preparations.
Es wurde nun überraschenderweise gefunden, dass Nerolidol, seine Ester und/oder Äther, die im folgenden als Deri- It has now surprisingly been found that nerolidol, its esters and / or ethers, hereinafter referred to as deri
Schema A q ® Scheme A q ®
! !
-P-0 -P-0
20 20th
25 25th
vate bezeichnet werden, als Bestandteil von kosmetischen Zubereitungen, bei ihrer Verwendung, auf der Haut eine pflegende Wirkung entfalten. vate, as a component of cosmetic preparations, when used, have a nourishing effect on the skin.
Neben der Pflegewirkung weist Nerolidol und seine Derivate bereits bei der Herstellung der kosmetischen Zubereitung durch seine Emulgierwirkung Vorteile auf. Weiterhin ist Nerolidol bzw. seine Ester und Äther, verglichen mit bisher verwendeten Naturstoffen, stabiler gegen Oxidation. In addition to the care effect, nerolidol and its derivatives already have advantages in the manufacture of the cosmetic preparation due to its emulsifying action. Furthermore, Nerolidol or its esters and ethers are more stable against oxidation compared to natural substances previously used.
Die Erfindung betrifft deshalb kosmetische Zubereitungen, insbesondere Pflegeprodukte, welche Nerolidol, dessen Ester und/oder Äther als hautpflegende Komponente enthalten. The invention therefore relates to cosmetic preparations, in particular care products, which contain nerolidol, its ester and / or ether as a skin-care component.
Nerolidol ist in vielen natürlich vorkommenden ätheri-30 sehen Ölen, wie z.B. Jasminblütenöl, Verbenaöl, Orangen-blütenöl, Neroliöl usw., enthalten [E. Gildemeister & Fr. Hoffmann, «Die ätherischen Öle», Bd. Illb, (Berlin, 1962), S. 239], und wurde bereits als Riechstoff in verschiedenen Zubereitungen eingesetzt. Nerolidol is found in many naturally occurring ethereal oils, such as Jasmine flower oil, verbena oil, orange flower oil, neroli oil etc. contain [E. Gildemeister & Fr. Hoffmann, "The essential oils", Vol. Illb, (Berlin, 1962), p. 239], and has already been used as a fragrance in various preparations.
35 Weiterhin weist Nerolidol und die Nerolidol enthaltenden Zubereitungen und natürlichen Öle antimikrobielle Eigenschaften auf [J.A. Morris, A. Khettry & E.W. Seitz, J. Am. Oil Chem. Soc. 56(5), (1979) 595]. 35 Furthermore, nerolidol and the preparations and natural oils containing nerolidol have antimicrobial properties [J.A. Morris, A. Khettry & E.W. Seitz, J. Am. Oil Chem. Soc. 56 (5), (1979) 595].
G. Popjak & J.W, Cornforth, Advances in Enzymology 40 22 (I960) 281 und L. Gosselin & J. Duvivier, Bull. Soc. G. Popjak & J.W. Cornforth, Advances in Enzymology 40 22 (I960) 281 and L. Gosselin & J. Duvivier, Bull. Soc.
Chim. Biol. 47, (1965) 359 haben experimentell gezeigt, dass die Phosphatform von Nerolidol mit enzymatischen Systemen aus Leberhomogenaten zu Squalen metabolisiert werden kann. Letzteres kann dann weiter in Steroide, wie 45 Lanosterin, Cholesterin usw., übergeführt werden. Diese bekannten Reaktionen sind in Schema A und B nachfolgend dargestellt: Chim. Biol. 47, (1965) 359 have shown experimentally that the phosphate form of nerolidol can be metabolized to squalene with enzymatic systems from liver homogenates. The latter can then be further converted into steroids such as 45 lanosterol, cholesterol, etc. These known reactions are shown in Schemes A and B below:
Farnesylpyrophosphat Farnesyl pyrophosphate
0" 0H I I û P-O-P-O I! » 0 "0H I I û P-O-P-O I!»
0 0 0 0
Nerolidylpyrophosphat Nerolidyl pyrophosphate
NADPH + H® NADPH + H®
( (
*NADP * NADP
633 708 633 708
Squalen Squalene
Schema B Scheme B
Squalen Squalene
Lanosterin Lanosterol
Cholesterin cholesterol
NADPH = reduziertes Nicotinamid-adenin-dinucleotid-phosphat NADP® = Nicotinamid-adenin-dinucleotid-phosphat NADPH = reduced nicotinamide adenine dinucleotide phosphate NADP® = nicotinamide adenine dinucleotide phosphate
Es wird vermutet, dass Nerolidol bzw. seine Derivate, durch Enzymsysteme, welche auf der menschlichen Haut üblicherweise vorkommen und/oder durch Enzymsysteme von Mikroorganismen, welche sich auch auf der Haut befinden, in der oben angegebenen Weise metabolisieren können und dadurch die hautpflegende Wirkung entsteht. Eine solche Metabolisierung ist schon darum überraschend, weil vom Fachmann erwartet werden konnte, dass durch die bekannte antimikrobielle Eigenschaft des Nerolidols auch die entsprechende enzymatische Wirkung beeinträchtigt würde. It is assumed that nerolidol or its derivatives can be metabolized in the manner indicated above by enzyme systems which are usually found on human skin and / or by enzyme systems of microorganisms which are also on the skin, and this results in the skin-caring effect . Such a metabolism is surprising, because the person skilled in the art could have expected that the known antimicrobial property of nerolidol would also impair the corresponding enzymatic action.
Die erfindungsgemässen kosmetischen Zubereitungen können in Form von Reinigungs-, Verschönerungs- oder Pflegepräparaten vorliegen. Beispiele für solche kosmetische Zubereitungen sind: The cosmetic preparations according to the invention can be in the form of cleaning, beautifying or care preparations. Examples of such cosmetic preparations are:
Badepräparate, Haut- und Haarwaschmittel, wie Seifen, Schaumbäder, Badeöle, Schaumcrèmebâder, Shampoos; Gesichtswässer, Körperlotionen, Hautöle, Hautcremes, Lippenpflegemittel, Gesichtspackungen, Hautreinigungsmittel, Gesichtswässer, Lichtschutzmittel, Hautbräunungsmittel, Hautbleichmittel, insektenabwehrende Mittel, Deodorants, Antitranspirants; Intimpflegemittel, wie Intimwaschmittel und Intimdeodorants; Fusspflegemittel, wie Fussbadeessenzen, Fusspuder, Fusslotionen, Fusscrèmes, Fusssprays; Aknemittel; Rasierhilfsmittel, wie Rasierwässer, Pre-Shave-Mittel, After-Shave-Mittel; Haarwässer, Haaröle, Haarfixiermittel, Haarlacke, Haarfestiger, Haarspülmittel, Haarkuren; Gesichtspflegemittel, Puder, Augenpflegemittel, Lippenstifte, Nagelpflegemittel. Bath preparations, skin and hair detergents, such as soaps, foam baths, bath oils, foam cream baths, shampoos; Facial lotions, body lotions, skin oils, skin creams, lip care products, face packs, skin cleansers, facial lotions, light protection agents, skin tanning agents, skin bleaching agents, insect repellants, deodorants, antiperspirants; Intimate hygiene products such as intimate detergents and intimate deodorants; Foot care products, such as foot bath essences, foot powder, foot lotions, foot creams, foot sprays; Acne remedies; Shaving aids such as aftershave, pre-shave, after-shave; Hair lotions, hair oils, hair fixatives, hair lacquers, hair fixatives, hair rinses, hair treatments; Face care products, powder, eye care products, lipsticks, nail care products.
Nerolidol, seine Ester und Äther weisen neben der leichten und ökonomischen Zugänglichkeit auch verschiedene andere Vorteile auf. So zeigt Nerolidol in den kosmetischen Zubereitungen eine emulgierende Wirkung und ist stabil gegen Oxydation, weshalb entsprechende Zubereitungen längerfristig gut lagerbar sind. Dies im Gegensatz beispielsweise zu Squalen, welches leicht oxydiert wird und damit hergestellte Zubereitungen eine entsprechend kürzere Lagerzeit aufweisen. Nerolidol, its esters and ethers have various other advantages in addition to being easy and economical to access. Nerolidol has an emulsifying effect in the cosmetic preparations and is stable against oxidation, which is why the corresponding preparations can be stored well in the long term. This is in contrast to squalene, for example, which is easily oxidized and the preparations made with it have a correspondingly shorter storage time.
Nerolidol hat noch den zusätzlichen Vorteil, dass es toxikologisch unbedenklich ist. Es ist in den meisten Ländern sogar als Lebensmittelzusatz zugelassen. Nerolidol has the additional advantage that it is toxicologically safe. It is even approved as a food additive in most countries.
Die erfindungsgemässen Zubereitungen wurden von Testpersonen sehr positiv beurteilt. Frauen, welche die erfindungsgemässen kosmetischen Zubereitungen verwendet haben, haben unter anderem folgende Wirkungen festgestellt: Faltenglättung, Feuchtigkeitserhöhung der Haut und Hautelastizitätserhöhung. The preparations according to the invention were assessed very positively by test subjects. Women who have used the cosmetic preparations according to the invention have found, among other things, the following effects: wrinkle smoothing, increased moisture in the skin and increased skin elasticity.
Es wird vermutet, dass Nerolidol, seine Derivate bzw. 30 seine durch Enzymeinwirkung entstehenden Metabolite eine Stimulierung des Hautstoffwechsels bewirken. Um eine bessere Ausnützung dieser Stimulierung zu erzielen, werden den erfindungsgemässen Zubereitungen vorzugsweise Nährstoffe für die Haut, wie z.B. Kollagen und Natural Moisture Fak-35 tor (NMF), zugegeben. Bei Kollagen handelt es sich um ein Protein, welches biochemisch zu zelleigenem Material verarbeitet werden kann. Natural Moisture Faktor ist eine in der Kosmetik übliche Bezeichnung für ein vorwiegend Aminosäuren enthaltendes Gemisch von Substanzen, welches in 40 seiner Zusammensetzung dem hauteigenen Feuchthaltefaktor entspricht. It is believed that nerolidol, its derivatives, or its metabolites, which are produced by the action of enzymes, stimulate the skin's metabolism. In order to achieve a better use of this stimulation, the preparations according to the invention are preferably nutrients for the skin, such as e.g. Collagen and natural moisture factor 35 (NMF) added. Collagen is a protein that can be processed biochemically into the cell's own material. Natural moisture factor is a common name in cosmetics for a mixture of substances that mainly contains amino acids, the composition of which corresponds to the skin's own moisturizing factor.
Selbstverständlich können die erfindungsgemässen Zubereitungen weitere andere für kosmetische Zubereitungen übliche und für die jeweilige Verwendung geeignete Substanzen 45 enthalten. Hierzu gehören z.B.: Of course, the preparations according to the invention can contain further other substances 45 which are customary for cosmetic preparations and are suitable for the respective use. These include, for example:
Fette und flüssige Fette, Wachse und diesen ähnliche Stoffe natürlichen und/oder synthetischen Ursprungs; Ten-side; Emulgatoren; Lösungsvermittler; Lösungsmittel; hy-drokolloide und filmbildende Stoffe; Treibgase; Farbstoffe; so Aromastoffe; Parfümöle und Riechstoffe; Feuchthaltemittel; antimikrobiell wirksame Stoffe als Konservierungsmittel; Antioxydantien und Stabilisatoren; Pflanzen- und Organextrakte; pH-Wert-regulierende Zusätze; Vitamine; Lichtschutzmittel; entzündungshemmend wirkende Zusätze; 55 Hautbräunungsmittel; Hautbleichmittel; insektenabwehrende Mittel. Fats and liquid fats, waxes and similar substances of natural and / or synthetic origin; Ten-side; Emulsifiers; Solubilizer; Solvent; hydro-colloidal and film-forming substances; Propellants; Dyes; so flavorings; Perfume oils and fragrances; Humectants; antimicrobial substances as preservatives; Antioxidants and stabilizers; Plant and organ extracts; pH regulating additives; Vitamins; Sunscreen; anti-inflammatory additives; 55 skin tanning agents; Skin bleach; insect repellent.
Nerolidol und seine Derivate sind auch leicht und auf ökonomische Weise zugänglich. Sie können nach bekannten Verfahren aus pflanzlichen Quellen isoliert oder synthetisch 60 hergestellt werden. Solche Verfahren sind beispielsweise in I.N. Nazarov et al., Zhur. Obshcheï Khim. 28, (1958), S. 1444; vgl. auch Chem. Abstr. 53, (1959), S. 1102 i; CH-PS 261 120, GB-PS 774 621 und der US-PS 2 841 620 beschrieben. Nerolidol and its derivatives are also easily and economically accessible. They can be isolated from plant sources by known methods or synthetically produced. Such methods are described, for example, in I.N. Nazarov et al., Zhur. Obshcheï Khim. 28, (1958), p. 1444; see. also Chem. Abstr. 53, (1959), p. 1102 i; CH-PS 261 120, GB-PS 774 621 and US-PS 2 841 620.
65 Die Erfindung wird anhand der nachfolgenden Beispiele weiter veranschaulicht, wobei die Emulgatorwirkung und die Verbesserung der Crèmestruktur anhand von Vergleichsbeispielen gezeigt wird. 65 The invention is illustrated further with the aid of the examples below, the emulsifier action and the improvement in the cream structure being shown with the aid of comparative examples.
633708 633708
4 4th
Beispiel 1 (Emulsion) Example 1 (emulsion)
Beispiel la) (gemäss der Erfindung) Example la) (according to the invention)
A) Isopropylmyristinat 100 g Nerolidol 50 g Glycerinmonostearat 5 g «Amphisol»* 2 g A) Isopropyl myristinate 100 g nerolidol 50 g glycerol monostearate 5 g «amphisole» * 2 g
B) Propylenglykol 50 g Wasser 670 g Total 877 g B) Propylene glycol 50 g water 670 g total 877 g
Beispiel lb) (Vergleich) Example lb) (comparison)
A) Isopropylmyristinat Glycerinmonostearat «Amphisol» A) Isopropyl myristinate glycerol monostearate «Amphisol»
B) Propylenglykol Wasser Total B) Total propylene glycol water
150 g 12,5 g 5 g 50 g 670 g 887,5 g 150 g 12.5 g 5 g 50 g 670 g 887.5 g
A) A)
Isopropylmyristinat Isopropyl myristinate
100 g 100 g
Squalan Squalane
50 g 50 g
Glycerinmonostearat Glycerol monostearate
12,5 g 12.5 g
«Amphisol» «Amphisole»
5 g 5 g
B) B)
Propylenglykol Propylene glycol
50 g 50 g
Wasser water
670 g 670 g
Total Total
887,5 g 887.5 g
Wurde das verzweigtkettige Nerolidol des Beispiels la) durch eine äquivalente Menge des ebenfalls eine verzweigte Kohlenstoffkette aufweisenden Squalans ersetzt, erhielt man dadurch ein ebenfalls beträchtlich schwerer zu emulgieren-des System als das unter Beispiel la) erwähnte. So liess sich mittels eines Vorgehens, das demjenigen der Beispiele la) und lb) entsprach (Zugabe des Emulgatorenpaares in ansteigender Menge), zeigen, dass auch hier die ca. 2,5fache Emulgatorenmenge bezüglich des Beispiels la) eingesetzt werden musste, um eine entsprechende Emulgierung zu erreichen. If the branched-chain nerolidol of example la) was replaced by an equivalent amount of squalane, which likewise has a branched carbon chain, this gave a system which was also considerably more difficult to emulsify than that mentioned in example la). Using a procedure that corresponded to that of examples la) and lb) (addition of the emulsifier pair in increasing amounts), it could be shown that here too, approximately 2.5 times the amount of emulsifier with respect to example la) had to be used in order to obtain a corresponding one To achieve emulsification.
Beispiel 2 Example 2
Der Effekt von Nerolidol auf Konsistenz, Oberflächenstruktur und Weichheit einer Crème wurde an Hand einer stearinsäurereichen O/W-Emulsion vom Tagescrème-Typ in s den Beispielen 2a) und 2b) untersucht. The effect of nerolidol on the consistency, surface structure and softness of a cream was investigated using a stearic acid-rich o / w emulsion of the day cream type in s Examples 2a) and 2b).
10 10th
* Amphisol = Diäthanoiammoniumsalz eines partiellen Phos-phorsäurealkylesters (ex Givaudan). * Amphisol = diethanoiammonium salt of a partial phosphoric acid alkyl ester (ex Givaudan).
Durch sukzessives Zufügen des Emulgatorenpaares Glycerinmonostearat und «Amphisol» in einem Gewichtsverhältnis von 5: 2 konnte gezeigt werden, dass, bereits nach Zugabe von 5 g Glycerinmonostearat und 2 g «Amphisol» zur obigen Grundmasse (bestehend aus Isopropylmyristinat und Nerolidol), sieh diese emulgieren liess. By successively adding the pair of emulsifiers glycerol monostearate and «amphisole» in a weight ratio of 5: 2 it could be shown that, after adding 5 g glycerol monostearate and 2 g «amphisole» to the above base (consisting of isopropyl myristinate and nerolidol), they emulsify left.
Sowohl die Fettphase A) wie die Wasserphase B) wurden auf 75 °C erwärmt. Danach wurde B) zu der mit einem Tur-binenrührer gerührten Phase A) gegeben, und die Zubereitung wurde unter gutem Rühren auf Raumtemperatur abkühlen gelassen. Both the fat phase A) and the water phase B) were heated to 75 ° C. Thereafter, B) was added to phase A), which was stirred with a turbine stirrer, and the preparation was allowed to cool to room temperature with good stirring.
15 15
20 20th
Beispiel 2a) (Tagescrème) Example 2a) (day cream)
A) Stearin Nerolidol A) Stearin nerolidol
Isopropylmyristinat Glycerinmonostearat «Amphisol» Isopropyl myristinate glycerol monostearate «Amphisol»
«Sterilip»* "Sterilip" *
«Anoxol»** "Anoxol" **
«Irgasan DP 300»*** "Irgasan DP 300" ***
B) Propylenglykol Wasser B) propylene glycol water
«Sterilaqua»**** "Sterilaqua" ****
C) Parfüm Total C) Total perfume
70 50 100 30 10 5 5 3 70 50 100 30 10 5 5 3
50 666,5 g 3 g 7,5 g 1000,0 g 50 666.5 g 3 g 7.5 g 1000.0 g
Die Fettphase bestand nur aus Isopropylmyristinat. Nerolidol wurde in diesem Experiment völlig weggelassen; men-genmässig wurde es jedoch durch Zusatz eines entsprechenden Anteils an Isopropylmyristinat kompensiert. The fat phase consisted only of isopropyl myristinate. Nerolidol was completely omitted in this experiment; In terms of quantity, however, it was compensated for by adding a corresponding proportion of isopropyl myristinate.
Dabei zeigte sich, dass, bei ansteigender Zugabe beider Emulgatoren in dem in Beispiel la) erwähnten Verhältnis, eine Emulgierung erst nach Zusatz von 12,5 g Glycerinmonostearat und 5 g «Amphisol» erreicht werden konnte. Es brauchte also, verglichen mit Beispiel la), die 2,5fache Menge an Emulgatorengemisch bei gleichen Bedingungen, um eine Emulsion zu erhalten. It was found that, with increasing addition of both emulsifiers in the ratio mentioned in Example la), emulsification could only be achieved after the addition of 12.5 g glycerol monostearate and 5 g «amphisol». Compared to Example la), it took 2.5 times the amount of emulsifier mixture under the same conditions to obtain an emulsion.
Beispiel lc) (Vergleich) Example lc) (comparison)
* «Sterilip» = Konservierungsmittel vom p-Hydroxibenzoe-säureester-Typ der Codive AG, CH-6300 Zug ** «Anoxol» = Synergetisches Antioxidans der Codiva AG, 25 CH-6300 Zug * "Sterilip" = preservative of the p-hydroxibenzoic acid ester type from Codive AG, CH-6300 Zug ** "Anoxol" = synergetic antioxidant from Codiva AG, 25 CH-6300 Zug
*** «Irgasan DP 300» = Konservierungsmittel vom Typus eines polychlorierten Phenols der Ciba-Geigy AG, CH-4002 Basel **** «Sterilaqua» = vom Imidazolidinylharnstoff-Typ der Codiva AG, CH-6300 Zug *** "Irgasan DP 300" = preservative of the polychlorinated phenol type from Ciba-Geigy AG, CH-4002 Basel **** "Sterilaqua" = from the imidazolidinyl urea type from Codiva AG, CH-6300 Zug
30 Die Fettphase A) sowie die Wasserphase B) wurden auf 75 °C erhitzt; danach wurde die Wasserphase langsam zu der mit dem Turbinenrührer gerührten Fettphase zugegeben. Es wurde, unter weiterem Rühren, auf ca. 35 °C abgekühlt, und ebenfalls unter Rühren wurde die Parfümphase C) zugege-35 ben. Nach Erreichen der Raumtemperatur wurde das Rühren eingestellt. 30 Fat phase A) and water phase B) were heated to 75 ° C; then the water phase was slowly added to the fat phase stirred with the turbine stirrer. The mixture was cooled to about 35 ° C. with further stirring, and the perfume phase C) was also added with stirring. After the room temperature had been reached, the stirring was stopped.
40 40
45 45
50 50
Beispiel 2b) (Vergleich) Example 2b) (comparison)
A) Stearin Isopropylmyristinat Glycerinmonostearat «Amphisol» A) Stearin isopropyl myristinate Glycerin monostearate «Amphisol»
«Sterilip» "Sterilip"
«Anoxol» "Anoxol"
«Irgasan DP 300» "Irgasan DP 300"
B) Propylenglykol Wasser «Sterilaqua» B) Propylene glycol water "Sterilaqua"
C) Parfüm Total C) Total perfume
70 g 100 g 30 g 10 g 5 g 5 g '3 g 50 g 666,5 g 3 g 7,5 g 950,0 g 70 g 100 g 30 g 10 g 5 g 5 g '3 g 50 g 666.5 g 3 g 7.5 g 950.0 g
Nerolidol wurde vollständig weggelassen. Die übrigen Emulsionsbestandteile entsprechen jenen in Beispiel 2a) und wurden auch in denselben Mengen und unter den gleichen 55 Bedingungen eingesetzt. Ein Vergleich der beiden Emulsionen zeigt sofort, dass diejenige von Beispiel 2a) durch den Zusatz von Nerolidol viel weicher, von glätterer Oberfläche und von ansprechenderer Struktur ist. Beim Auftragen auf die Haut erzeugt sie ein weiches, angenehmes Gefühl und 6o zeigt ein ausgeprägteres Spreitvermögen. Zudem ist das bei stearinhaltigen Crèmes normalerweise anzutreffende Weissein auf der Haut durch den Nerolidol-Zusatz stark reduziert. Nerolidol has been completely omitted. The remaining emulsion components correspond to those in Example 2a) and were also used in the same amounts and under the same conditions. A comparison of the two emulsions immediately shows that that of example 2a) is much softer due to the addition of nerolidol, of a smoother surface and of a more appealing structure. When applied to the skin, it creates a soft, pleasant feeling and 6o shows a more pronounced spreading ability. In addition, the whiteness normally found on creams containing stearin is greatly reduced by the addition of nerolidol.
65 Beispiel 3 (Nährende Tagescrème) 65 Example 3 (Nourishing Day Cream)
Eine Tagescrème wurde wie in Beispiel 2b) hergestellt. Zur Fettphase A) wurden noch 10 g Nerolidol und zur Wasserphase B) 10 g Kollagen gegeben. A day cream was prepared as in Example 2b). 10 g of nerolidol were added to the fat phase A) and 10 g of collagen to the water phase B).
Beispiel 4 (Befeuchtende Tagescrème) Example 4 (Moisturizing Day Cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 10 g Nerolidol und zur Wasserphase B) 10 g NMF als Feuchtefaktor («Dermamoist-NMF» der Codiva AG, CH-6300 Zug) zugegeben. A day cream according to Example 2b) was produced. 10 g of nerolidol and 10 g of NMF as moisture factor (“Dermamoist-NMF” from Codiva AG, CH-6300 Zug) were added to the fat phase A) and to the water phase B).
Beispiel 5 (Tagescrème) Example 5 (day cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 10 g Nerolidol und zur Wasserphase B) 10 g Kollagen und 10 g NMF zugegeben. A day cream according to Example 2b) was produced. 10 g of nerolidol were added to the fat phase A) and 10 g of collagen and 10 g of NMF to the water phase B).
Beispiel 6 (Tagescrème) Example 6 (day cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 10 g Nerolidol und zur Wasserphase B) 10 g Panthenol zugegeben. A day cream according to Example 2b) was produced. 10 g of nerolidol were added to the fat phase A) and 10 g of panthenol to the water phase B).
Beispiel 7 (Tagescrème) Example 7 (day cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 10 g Nerolidol und zur Wasserphase B) 10 g Panthenol und 10 g Kollagen zugegeben. A day cream according to Example 2b) was produced. 10 g of nerolidol were added to the fat phase A) and 10 g of panthenol and 10 g of collagen were added to the water phase B).
Beispiel 8 (Tagescrème) Example 8 (day cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 200 g Nerolidol zugegeben. A day cream according to Example 2b) was produced. 200 g of nerolidol were added to the fat phase A).
Beispiel 9 (Tagescrème) Example 9 (day cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 0,1 g Nerolidol zugegeben. A day cream according to Example 2b) was produced. 0.1 g of nerolidol was added to the fat phase A).
Beispiel 10 (Tagescrème) Example 10 (day cream)
Eine Tagescrème gemäss Beispiel 2b) wurde hergestellt. Zur Fettphase A) wurden noch 7 g Nerolidol zugegeben. A day cream according to Example 2b) was produced. 7 g of nerolidol were added to the fat phase A).
Beispiel 11 (Nachtcrème) Example 11 (night cream)
«Protegin»* "Protegin" *
180 g 180 g
Lanolin lanolin
80 g 80 g
Bienenwachs Beeswax
35 g 35 g
Mikrokristalliner Wachs Microcrystalline wax
40 g 40 g
Perhydrosqualen Perhydroscalene
80 g 80 g
Nerolidol Nerolidol
10 g 10 g
Paraflinöl Paraflin oil
150 g 150 g
CetiolV CetiolV
100 g 100 g
«Sterilip» "Sterilip"
5g 5g
«Anoxol» "Anoxol"
5g 5g
Magnesiumsulfat Magnesium sulfate
2g 2g
«Sterilaqua» "Sterilaqua"
3g 3g
Wasser water
302 g 302 g
Parfüm Perfume
8g 8g
Total Total
1000 g 1000 g
* Von der Th. Goldschmidt AG, D-43 Essen Das Vermischen erfolgte analog zu Beispiel 2a). * From Th. Goldschmidt AG, D-43 Essen The mixing was carried out analogously to Example 2a).
633708 633708
Beispiel 12 (Gesichtsöl) Example 12 (face oil)
«PCL, liquid»* "PCL, liquid" *
100 g 100 g
Olivenöl olive oil
300 g 300 g
Nerolidol Nerolidol
10 g 10 g
«Miglyol 812»** "Miglyol 812" **
200 g 200 g
«Cetiol V»**** "Cetiol V" ****
300 g 300 g
Avocadoöl Avocado oil
60 g 60 g
Johanniskrautöl*** St. John's wort oil ***
10 g 10 g
Vitaminöl*** Vitamin oil ***
10 g 10 g
«Anoxol» "Anoxol"
10g 10g
Total Total
1000 g 1000 g
* Von Dragoco Gerberding & Co. GmbH, D-3450 Holzminden ** Von Dynamit Nobel, Werk Witten, D-581 Witten/Ruhr *** Von HACOBA AG, CH-4002 Basel **** Decyloleat der Firma Henkel KGaA, D-4000 Düsseldorf 1 * By Dragoco Gerberding & Co. GmbH, D-3450 Holzminden ** By Dynamit Nobel, Witten plant, D-581 Witten / Ruhr *** By HACOBA AG, CH-4002 Basel **** Decyl oleate from Henkel KGaA, D -4000 Dusseldorf 1st
Die Komponenten dieser Zubereitung wurden bei Raumtemperatur durch Rühren miteinander vermischt. The components of this preparation were mixed together at room temperature by stirring.
Beispiel 13 (Pflegender Lippenstift) Example 13 (Nourishing Lipstick)
Eosine Eosine
30 g 30 g
Pigmente und Farblacke Pigments and color varnishes
60 g 60 g
Ricinusöl Castor oil
140 g 140 g
Oleylalkohol Oleyl alcohol
160 g 160 g
Carnaubawachs Carnauba wax
90 g 90 g
Lanolin anhydr. Lanolin anhydr.
120 g 120 g
Bienenwachs Beeswax
140 g 140 g
«Comperlan HS»* "Comperlan HS" *
40 g 40 g
Ozokerit Ozokerite
70 g 70 g
«PCL, solid»** "PCL, solid" **
90 g 90 g
Kolophonium rosin
20 g 20 g
«Anoxol» "Anoxol"
10 g 10 g
Nerolidol Nerolidol
40 g 40 g
Parfüm Perfume
10 g 10 g
1020 g 1020 g
* Von Henkel KGaA, D-4000 Düsseldorf 1 ** Von Dragoco Gerberding & Co. GmbH, D-3450 Holzminden * From Henkel KGaA, D-4000 Düsseldorf 1 ** From Dragoco Gerberding & Co. GmbH, D-3450 Holzminden
Herstellung: Pigmente und Farblacke wurden gründlich gemischt, durch ein feines Sieb gestrichen, mit einem Teil des Oleylalkohols benetzt und in einer Kolloidmühle vermählen. Danach wurde die Farbmasse zu den übrigen Rohstoffen gegeben und mit diesen unter gutem Rühren geschmolzen. Die erhaltene Lippenstiftmasse wurde in die vorgewärmten Giessformen gegossen, die danach abgekühlt wurden. Nach Erreichen der Raumtemperatur wurden die Stifte den Formen entnommen, und durch Abflammen mit einem Bunsenbrenner wurde ihre Oberflächenbeschaffenheit verbessert. Production: Pigments and colored lacquers were mixed thoroughly, passed through a fine sieve, wetted with part of the oleyl alcohol and ground in a colloid mill. Then the color mass was added to the other raw materials and melted with good stirring. The lipstick mass obtained was poured into the preheated molds, which were then cooled. After reaching room temperature, the pins were removed from the molds and their surface quality was improved by flaming with a Bunsen burner.
5 5
5 5
10 10th
15 15
20 20th
25 25th
30 30th
35 35
40 40
45 45
50 50
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH896380A CH633708A5 (en) | 1980-12-04 | 1980-12-04 | COSMETIC PREPARATION. |
DE19813147911 DE3147911A1 (en) | 1980-12-04 | 1981-12-03 | Cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH896380A CH633708A5 (en) | 1980-12-04 | 1980-12-04 | COSMETIC PREPARATION. |
Publications (1)
Publication Number | Publication Date |
---|---|
CH633708A5 true CH633708A5 (en) | 1982-12-31 |
Family
ID=4346791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH896380A CH633708A5 (en) | 1980-12-04 | 1980-12-04 | COSMETIC PREPARATION. |
Country Status (2)
Country | Link |
---|---|
CH (1) | CH633708A5 (en) |
DE (1) | DE3147911A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284802B1 (en) | 1999-04-19 | 2001-09-04 | The Procter & Gamble Company | Methods for regulating the condition of mammalian keratinous tissue |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB774621A (en) * | 1954-05-11 | 1957-05-15 | Hoffmann La Roche | Novel acetylenic esters and the conversion thereof into further esters |
-
1980
- 1980-12-04 CH CH896380A patent/CH633708A5/en not_active IP Right Cessation
-
1981
- 1981-12-03 DE DE19813147911 patent/DE3147911A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE3147911A1 (en) | 1982-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69828631T2 (en) | SPINALS BASED ON JOJOBA OIL | |
DE69526966T2 (en) | SKIN-STRENGTHING COMETIC COMPOSITION | |
DE3302898C2 (en) | ||
DE69004212T2 (en) | Skin coloring composition containing indole derivatives and dihydroxyacetone. | |
US4393043A (en) | Solutions containing at least one essential fatty acid and vegetable oil, and cosmetic compositions containing these solutions | |
DE69011439T2 (en) | New cosmetic products containing chitosan and glucosamine. | |
DE69500077T2 (en) | Cosmetic and dermatological composition consisting of an oily bead and oil-in-water emulsion coated with lamellar liquid crystals | |
EP0556660B1 (en) | Utilisation of fatty alpha-hydroxy acids | |
EP0600931B1 (en) | Cosmetic sticks | |
DE69506363T2 (en) | Use of an oil rich in petroselinic acid as a humectant | |
DE69427498T2 (en) | Process for stabilizing vesicles from amphiphilic lipids and composition containing these stabilized vesicles for topical use | |
DE69005801T2 (en) | Cosmetic composition for topical use, containing essential oils. | |
DE69201504T2 (en) | Cosmetic composition in the form of a triple emulsion. | |
EP0674505A1 (en) | Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails | |
DE69313073T2 (en) | LANOLIN FATTY ACID, YOUR SEPARATION, AND COSMETIC AND EXTERNAL APPLICATION | |
US4324802A (en) | Cosmetic oil and composition containing the same | |
DE69800170T2 (en) | System consisting of phosphonic acid derivatives and metabisulphite to stabilize ascorbic acid | |
DE69311541T2 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING THE DEACYLATED GLYCEROPHOSPHOLIPIDES | |
DE69403025T2 (en) | Cosmetic or dermatological preparation in the form of a stable oil-in-water emulsion which contains at least one vegetable oil which consists of at least 40% linoleic acid triglyceride | |
DE2408663C2 (en) | ||
DE68915191T2 (en) | Use of polyacrylate polymers as stabilizers for suspensions, suspensions obtained from a water-insoluble phase in an aqueous phase and their preparation. | |
EP0945122B1 (en) | Haircare composition containing gamma-oryzanol and calcium salts | |
EP0231777A1 (en) | Moist keeping cosmetics and their use | |
DE2524297B2 (en) | Cosmetic product with a skin softening effect | |
DE69903959T2 (en) | COSMETIC PREPARATIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PFA | Name/firm changed |
Owner name: CODIVA AG |
|
PL | Patent ceased | ||
PL | Patent ceased |